Barrett oesophagus

Risk stratification using Cytosponge

A device called Cytosponge could be used to identify patients with Barrett oesophagus at low-risk of disease progression, according to the BEST2 study group. Cytosponge is a foam sphere within a gelatine capsule on a string that expands in the stomach after swallowing. When pulled from the stomach, the sponge enables collection of cells along the entire oesophagus, minimizing sampling bias. A multicentre discovery cohort of patients with Barrett oesophagus (n = 468) were tested with Cytosponge to identify clinical and molecular biomarkers that could stratify patients by risk. The optimum panel consisted of age, Barrett segment length, BMI, TP53 mutation status, Aurora kinase A expression and presence of glandular atypia. The model was validated in an independent cohort (n = 65), scoring 38% at low-risk for malignant progression. These patients could be spared invasive and expensive endoscopic surveillance, enabling prioritization for those at higher risk.


  1. 1

    Ross-Innes, C. S. et al. Risk stratification of Barrett's oesophagus using non-endoscopic sampling method coupled with a biomarker panel: a cohort study. Lancet Gasterol. Hepatol. (2016)

Download references


Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Dickson, I. Risk stratification using Cytosponge. Nat Rev Gastroenterol Hepatol 14, 4 (2017).

Download citation

Further reading


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing